NASDAQ: QSQuantumscape Corp Stock
$5.18+0.29 (+5.93%)
Updated Jul 27, 2026
QS Price
$5.18
Fair Value Price
$0.28
Market Cap
$3.21B
52 Week Low
$4.81
52 Week High
$19.07
P/E
-7.73x
P/B
3.06x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$404.97M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.12
Operating Cash Flow
-$236M
Beta
2.23
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A
QS Overview
QuantumScape Corporation develops lithium-metal batteries for electic vehicles. QuantumScape was founded in 2010 and is headquartered in San Jose, CA.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine QS's potential to beat the market
FStrong Sell
- Stocks with a Zen Rating of Strong Sell (F) had an average loss of -12.86% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important QS news, forecast changes, insider trades & much more!
QS News
Overview
Due Diligence Score
–
Industry Average (35)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how QS scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
QS ($5.18) is overvalued by 1,770.2% relative to our estimate of its Fair Value price of $0.28 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
QS ($5.18) is not significantly undervalued (1,770.2%) relative to our estimate of its Fair Value price of $0.28 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
QS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more QS due diligence checks available for Premium users.
Valuation
QS fair value
Fair Value of QS stock based on Discounted Cash Flow (DCF)
Price
$5.18
Fair Value
$0.28
Overvalued by
1,770.20%
QS ($5.18) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
QS ($5.18) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
QS is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
QS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
-7.73x
Industry
27.85x
Market
14.17x
QS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
3.06x
Industry
1.92x
QS is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
QS's financial health
Profit margin
Revenue
$0.0
Net Income
-$98.2M
Profit Margin
0%
QS's cash burn is expected... subscribe to Premium to read more.
Interest Coverage Financials
Assets to liabilities
Assets
$1.2B
Liabilities
$120.8M
Debt to equity
0.12
QS's short-term assets ($869.09M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
QS's short-term assets ($869.09M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
QS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
QS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
-$56.7M
Investing
$32.1M
Financing
$12.5M
QS's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials
QS vs Auto Part Stocks
Quantumscape Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.